文献速递肝病消化道出血

急性静脉曲张出血循证治疗实施欠佳:观察性研究的系统评价

Suboptimal Implementation of Evidence-based Therapy for Acute Variceal Hemorrhage: A Systematic Review of Observational Studies.
PubMed 文献 · Clin Gastroenterol Hepatol · 2017-02-27

该系统评价纳入1990年1月至2016年9月的队列研究,汇总急性静脉曲张出血(AVH)的死亡率和治疗使用情况。AVH汇总6周死亡率为17.7%(95%CI 14.4%-21.7%),预防性抗生素使用率仅52.8%,硬化治疗和球囊压迫仍被使用,提示循证治疗实施欠佳,需质量改进。

要点

  • AVH汇总6周死亡率为17.7%(95%CI 14.4%-21.7%)。
  • 仅52.8%患者接受预防性抗生素(95%CI 40.0%-66.2%)。
  • 2000年后治疗患者 salvage 操作降至1.7%,球囊压迫8.7%。

核心结论

  • AVH与高死亡率相关,预防性抗生素和内镜干预等循证治疗实施欠佳,提示需要质量改进。
  • 球囊压迫和硬化治疗的频繁使用提示在消化内科培训课程中可能需特别关注这些操作。

研究设计与样本

  • 对1990年1月至2016年9月评估AVH结局和管理的队列研究进行系统评价。

主要发现

  • AVH汇总6周死亡率为17.7%(95%CI 14.4%-21.7%)。
  • 硬化治疗使用率为18.7%(95%CI 9.2%-34.3%),14.3%的患者未接受内镜干预(95%CI 9.7%-20.6%)。
  • 球囊压迫总体使用率为10.8%(95%CI 8.2%-14.1%),salvage 操作使用率为5.7%(95%CI 3.7%-8.6%),在2000年后治疗的患者中降至1.7%(95%CI 0.7%-3.8%)。
  • 及时内镜和血管活性药物使用的汇总率较高(分别为85.8%和83.0%),但仅半数患者接受预防性抗生素(52.8%;95%CI 40.0%-66.2%)。
  • 在仅纳入2000年后患者的研究中,13.8%接受硬化治疗(95%CI 7.0%-25.4%),salvage 经颈静脉肝内门体分流术降至1.7%(95%CI 0.7%-3.8%),球囊压迫略降至8.7%(95%CI 6.4%-11.6%),血管活性药物和预防性抗生素使用率分别升至91.4%(95%CI 86.0%-94.9%)和62.7%(95%CI 48.9%-74.9%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Gastroenterologists should strive to improve the outcomes associated with acute variceal hemorrhage (AVH) by optimizing care delivery and clinician preparedness through training. Unfortunately, data regarding contemporary outcomes and management of AVH are limited. METHODS: We performed a systematic review of cohort studies examining outcomes and management of AVH from January 1990 to September 2016. We pooled data on mortality and utilization of medical therapy, endoscopic interventions, balloon tamponade (BT), and salvage procedures (portal decompressive surgery or transjugular portosystemic shunt). RESULTS: The pooled 6-week mortality rate after AVH was 17.7% (95% confidence interval [CI], 14.4%-21.7%). Sclerotherapy was used in 18.7% of cases (95% CI, 9.2%-34.3%), and no endoscopic intervention was provided in 14.3% of patients (95% CI, 9.7%-20.6%). The overall rate of BT use was 10.8% (95% CI, 8.2%-14.1%). Salvage procedures were used in 5.7% (95% CI, 3.7%-8.6%), falling to 1.7% (95% CI, 0.7%-3.8%) among patients treated after 2000. Although pooled rates of timely endoscopy and vasoactive medication use were high (85.8% and 83.0%, respectively), only half of patients received prophylactic antibiotics (52.8%; 95% CI, 40.0%-66.2%). In studies that enrolled patients exclusively after 2000, 13.8% of patients (95% CI, 7.0%-25.4%) received sclerotherapy, salvage transjugular portosystemic shunt fell to 1.7% (95% CI, 0.7%-3.8%), BT use fell slightly to 8.7% (95% CI, 6.4%-11.6%), and vasoactive medication and prophylactic antibiotic use rose to 91.4% (95% CI, 86.0%-94.9%) and 62.7% (95% CI, 48.9%-74.9%), respectively. CONCLUSIONS: AVH is associated with high mortality rates and suboptimal implementation of evidence-based therapies including prophylactic antibiotics and endoscopic interventions, suggesting a need for quality improvement. In addition, the frequent need for BT and sclerotherapy suggests that specific attention to these procedures in gastroenterology training curricula may be warranted.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Tapper EB, Beste L, Curry M, et al. Suboptimal Implementation of Evidence-based Therapy for Acute Variceal Hemorrhage: A Systematic Review of Observational Studies. Clin Gastroenterol Hepatol. 2017. PMID: 28249809. doi:10.1016/j.cgh.2017.02.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。